Dairy and industrial sources of trans fat do not impair peripheral insulin sensitivity in overweight women

Am J Clin Nutr. 2009 Jul;90(1):88-94. doi: 10.3945/ajcn.2009.27515. Epub 2009 May 27.

Abstract

Background: The 2 major dietary sources of trans fatty acids (TFAs) are partially hydrogenated oils and ruminant-derived products. Epidemiologic data suggest that chronic consumption of industrial sources of TFAs could be damaging to insulin sensitivity, but intervention studies on this issue have remained inconclusive.

Objective: The trial was designed to compare the effects of dairy compared with industrial sources of TFAs on insulin sensitivity in overweight women.

Design: Sixty-three healthy women with abdominal obesity [waist circumference >88 cm and a body mass index (in kg/m(2)) >28] were recruited. After a run-in period, the volunteers were randomly assigned to consume 1 of 3 four-week diets: 60 g low-TFA lipids/d (0.54 g/d; n = 21), ruminant TFA-rich lipids (4.86 g/d; n = 21), or industrial TFA-rich lipids (5.58 g/d; n = 21). Changes in peripheral insulin sensitivity were assessed by using hyperinsulinemic-euglycemic clamps.

Results: After the intervention period, fasting glycemia and insulinemia and insulin sensitivity were not significantly modified in either group (P > 0.05).

Conclusions: These data indicate that consumption of dairy- and industrial-source TFAs for 4 wk at nutritional levels do not impair peripheral insulin sensitivity in insulin-resistant women. Our study may not preassess the effects of TFAs in normal insulin-sensitive individuals. This trial was registered at ClinicalTrials.gov as NCT00617435.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Body Composition
  • Body Mass Index
  • Dairy Products*
  • Dietary Fats / pharmacology
  • Double-Blind Method
  • Female
  • Glucose Clamp Technique
  • Humans
  • Hyperinsulinism
  • Insulin / pharmacology*
  • Insulin Resistance / physiology*
  • Obesity / blood*
  • Overweight / physiopathology*
  • Patient Compliance
  • Phospholipids / blood
  • Ruminants
  • Trans Fatty Acids / pharmacology*
  • Waist Circumference
  • Young Adult

Substances

  • Blood Glucose
  • Dietary Fats
  • Insulin
  • Phospholipids
  • Trans Fatty Acids

Associated data

  • ClinicalTrials.gov/NCT00617435